1Tantisira KG,Litonjua AA,Weiss ST,et al.Association of body mass with pulmonary in the function Childhood Asthma Management Program(CAMP)[J].Thorax,2003,58(12):1036-1041.
6Matsumoto K,Taki F, Miura M, et al. Serum levels of soluble IL-2R, IL-4 and soluble Fc epsilon R Ⅱ in adult bronchial asthma[J].Chest, 1994,105 (3) : 681 - 686.
7Gagro A, Rabatic S, Trescec A, et al. Expression of lymphocytes Fc epsilon RⅡ/CD23 in allergic children undergoing hyposen sitization[J]. kit Arch Allergy Immunol, 1993,101 (2) : 203-208.
8Hallstrand T, Auh K, Bates P, et al. Peripheral blood manifestations of Th2 lymphocyte activation in stable atopic asthma and during exercise- induced bronchospasm[J]. Ann Allergy Asthma Immunol, 1998,80( 5 ) : 424 -- 432.
9Hakansson L, Heinrich C, Rak S, et al. Activation of B-lymphocytes during pollen season. Effect of immunotherapy[J]. Clin Exp Allergy, 1998,28(7) : 791-798.
10Corominas M, Mestre M, Bas J, et al. Distinct modulation by interreron-gamma(IFN-gamma)of CD23 expression on B and T-lymphoeytes of atopic subjects[J]. Clin Exp Immunol, 1998,112 (2):276-280.
5Machida I, Matsuse H, Kondo Y, et al. Effects of various antiasthmatic agents on mite allergen-pulsed murine bone marrow- derived dendritic cells[J]. Clin Exp Allergy, 2005,35 (7) :884- 888.
6Panina-Bordignon P,Mazzeo D,Lucia PD, et al. Bete2-agonists prevent Thl development by selective inhibition of interleukin 12[J]. J Clin Invest, 1997,100(6) :1513-1519.
7Makhlouf K, Comabella M, Imitola J, et al. Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis[J]. J Neuroimmunol,2001,117(1/2) : 156-165.
